These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 27125460)

  • 1. ERRF is essential for Estrogen-Estrogen Receptor alpha signaling pathway in ER positive breast cancer cells.
    Luo A; Zhang X
    Biochem Biophys Res Commun; 2016 May; 474(2):400-405. PubMed ID: 27125460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of ERRF, a novel ER-related nuclear factor, in the growth control of ER-positive human breast cancer cells.
    Su D; Fu X; Fan S; Wu X; Wang XX; Fu L; Dong XY; Ni JJ; Fu L; Zhu Z; Dong JT
    Am J Pathol; 2012 Mar; 180(3):1189-1201. PubMed ID: 22341523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ERRF sensitizes ERBB2-positive breast cancer cells to lapatinib treatment likely by attenuating MCL1 and ERBB2 expression.
    Qi L; Zhang B; Zhang S; Ci X; Wu Q; Ma G; Luo A; Fu L; King JL; Nahta R; Dong JT
    Oncotarget; 2017 May; 8(22):36054-36066. PubMed ID: 28415602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four-and-a-half-LIM protein 1 down-regulates estrogen receptor α activity through repression of AKT phosphorylation in human breast cancer cell.
    Zhang F; Feng F; Yang P; Li Z; You J; Xie W; Gao X; Yang J
    Int J Biochem Cell Biol; 2012 Feb; 44(2):320-6. PubMed ID: 22094188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Estrogen Receptor Cofactor SPEN Functions as a Tumor Suppressor and Candidate Biomarker of Drug Responsiveness in Hormone-Dependent Breast Cancers.
    Légaré S; Cavallone L; Mamo A; Chabot C; Sirois I; Magliocco A; Klimowicz A; Tonin PN; Buchanan M; Keilty D; Hassan S; Laperrière D; Mader S; Aleynikova O; Basik M
    Cancer Res; 2015 Oct; 75(20):4351-63. PubMed ID: 26297734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low phosphorylation of estrogen receptor alpha (ERalpha) serine 118 and high phosphorylation of ERalpha serine 167 improve survival in ER-positive breast cancer.
    Yamashita H; Nishio M; Toyama T; Sugiura H; Kondo N; Kobayashi S; Fujii Y; Iwase H
    Endocr Relat Cancer; 2008 Sep; 15(3):755-63. PubMed ID: 18550720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospho-serine-118 estrogen receptor-alpha detection in human breast tumors in vivo.
    Murphy L; Cherlet T; Adeyinka A; Niu Y; Snell L; Watson P
    Clin Cancer Res; 2004 Feb; 10(4):1354-9. PubMed ID: 14977836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
    Lee YR; Park J; Yu HN; Kim JS; Youn HJ; Jung SH
    Biochem Biophys Res Commun; 2005 Nov; 336(4):1221-6. PubMed ID: 16169518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF-kappaB and estrogen receptor alpha interactions: Differential function in estrogen receptor-negative and -positive hormone-independent breast cancer cells.
    Gionet N; Jansson D; Mader S; Pratt MA
    J Cell Biochem; 2009 Jun; 107(3):448-59. PubMed ID: 19350539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of estrogen receptor α-36 by breast cancer oncogene IKKε promotes growth of ER-negative breast cancer cells.
    Li Q; Sun H; Zou J; Ge C; Yu K; Cao Y; Hong Q
    Cell Physiol Biochem; 2013; 31(6):833-41. PubMed ID: 23816933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
    Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
    Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER
    Formisano L; Stauffer KM; Young CD; Bhola NE; Guerrero-Zotano AL; Jansen VM; Estrada MM; Hutchinson KE; Giltnane JM; Schwarz LJ; Lu Y; Balko JM; Deas O; Cairo S; Judde JG; Mayer IA; Sanders M; Dugger TC; Bianco R; Stricker T; Arteaga CL
    Clin Cancer Res; 2017 Oct; 23(20):6138-6150. PubMed ID: 28751448
    [No Abstract]   [Full Text] [Related]  

  • 14. Epidermal growth factor induces WISP-2/CCN5 expression in estrogen receptor-alpha-positive breast tumor cells through multiple molecular cross-talks.
    Banerjee S; Sengupta K; Saxena NK; Dhar K; Banerjee SK
    Mol Cancer Res; 2005 Mar; 3(3):151-62. PubMed ID: 15798095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.
    Creighton CJ; Hilger AM; Murthy S; Rae JM; Chinnaiyan AM; El-Ashry D
    Cancer Res; 2006 Apr; 66(7):3903-11. PubMed ID: 16585219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidences that estrogen receptor α interferes with adiponectin effects on breast cancer cell growth.
    Mauro L; Pellegrino M; De Amicis F; Ricchio E; Giordano F; Rizza P; Catalano S; Bonofiglio D; Sisci D; Panno ML; Andò S
    Cell Cycle; 2014; 13(4):553-64. PubMed ID: 24335340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol synthesis inhibitor RO 48-8071 suppresses transcriptional activity of human estrogen and androgen receptor.
    Mafuvadze B; Liang Y; Hyder SM
    Oncol Rep; 2014 Oct; 32(4):1727-33. PubMed ID: 25051231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An inherent role of integrin-linked kinase-estrogen receptor alpha interaction in cell migration.
    Acconcia F; Manavathi B; Mascarenhas J; Talukder AH; Mills G; Kumar R
    Cancer Res; 2006 Nov; 66(22):11030-8. PubMed ID: 17108142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
    Imachi H; Murao K; Dobashi H; Bhuyan MM; Cao X; Kontani K; Niki S; Murazawa C; Nakajima H; Kohno N; Yamashita H; Iwase H; Hayashi S; Ishida T; Yamauchi A
    Breast Cancer Res Treat; 2010 Jul; 122(2):395-407. PubMed ID: 19847644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The estrogen receptor-interacting protein HPIP increases estrogen-responsive gene expression through activation of MAPK and AKT.
    Wang X; Yang Z; Zhang H; Ding L; Li X; Zhu C; Zheng Y; Ye Q
    Biochim Biophys Acta; 2008 Jun; 1783(6):1220-8. PubMed ID: 18302941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.